Public-registry site landscape for NCT04504383, a Ulcerative Colitis Chronic Moderate study sponsored by Protagonist Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04504383 (registry record) |
| Sponsor | Protagonist Therapeutics, Inc. |
| Condition(s) | Ulcerative Colitis Chronic Moderate; Ulcerative Colitis Chronic Severe |
| Phase | PHASE2 |
| Listed sites | 122 |
| Site countries | United States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Poland, Russia, Serbia, South Korea |
Eichor generates a preliminary site-risk snapshot for NCT04504383 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →